Table I.
BANCR expression | ||||||
---|---|---|---|---|---|---|
|
||||||
Characteristic | n | High (n=18) | % | Low (n=42) | % | P-value |
Age, years (mean ± SEM) | 60 | 60.4±17.3 | 64.6±14.5 | 0.333 | ||
Gender | 0.253 | |||||
Male | 35 | 13 | 37.1 | 22 | 62.9 | |
Female | 25 | 5 | 20.0 | 20 | 80.0 | |
Tumour size, cm | 0.253 | |||||
<4 | 25 | 5 | 20.0 | 20 | 80.0 | |
≥4 | 35 | 13 | 37.1 | 22 | 62.9 | |
Location | 0.167 | |||||
Colon | 32 | 7 | 21.9 | 25 | 78.1 | |
Rectum | 28 | 11 | 39.3 | 17 | 60.7 | |
Histological grade | 0.207 | |||||
Well/moderately | 44 | 11 | 25.0 | 33 | 75.0 | |
Poorly/other | 16 | 7 | 43.8 | 9 | 56.3 | |
Depth of invasion | 0.192 | |||||
T1, T2 | 15 | 2 | 13.3 | 13 | 86.7 | |
T3, T4 | 45 | 16 | 35.6 | 29 | 64.4 | |
Lymph node metastasis | 0.010b | |||||
Absent | 33 | 4 | 12.1 | 26 | 78.8 | |
Present | 27 | 14 | 51.9 | 16 | 59.3 | |
Serum CEA value, μg/l | 0.085 | |||||
<5 | 35 | 7 | 20.0 | 28 | 80.0 | |
≥5 | 25 | 11 | 44.0 | 14 | 56.0 | |
Tumour stagea | <0.001b | |||||
I, II | 28 | 2 | 7.0 | 26 | 93.0 | |
III, IV | 32 | 16 | 50.0 | 16 | 50.0 |
Tumour stage was obtained according to the tumour, node, metastasis criteria (National Comprehensive Cancer Network, 2012).
P<0.05 vs. present and III, IV.
BANCR, BRAF-activated long non-coding RNA; CEA, carcinoembryonic antigen; SEM, standard error of the mean.